@xconomy.com 6 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 2 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M